Extraosseous Tc-99m methylene diphosphonate concentration in the forearm following post-mastectomy lymphatic obstruction

INTRODUCTION

Lymphedema is a common complication of breast cancer treatment, especially after axillary lymph node dissection and radiotherapy. This condition may become apparent during routine bone imaging with Tc-99m methylene diphosphonate (MDP). In such cases, lymphoscintigraphy can be used to confirm obstruction to lymphatic drainage.

CASE REPORT

A 42-year-old female patient with a history of right breast cancer reported recent onset swelling of the right forearm. She had undergone modified radical mastectomy 2 years previously, with subsequent chemotherapy and radiotherapy. A routine whole-body bone scan was performed to assess any skeletal involvement. Following intravenous injection of 740 MBq (20 mCi) of Tc-99m MDP, imaging was performed after 3 hours under a dual head gamma camera (Ecam, Siemens, Germany) fitted with a low-energy high-resolution collimator. Diffuse soft tissue uptake of tracer in the right forearm, extending to the right elbow was noted [Figure 1]. No bony abnormality was detected.

Close

Figure 1 Anterior (a) and posterior; (b) whole-body bone scan images showing diffuse soft tissue uptake of tracer in the right forearm (arrows)

Export to PPT

A provisional diagnosis of lymphatic obstruction in the right upper limb was made and lymphoscintigraphy was performed during the patient's next visit, 7 days later. Unfiltered Tc99m-sulphur colloid (20 MBq) was injected intradermally into the second and third web spaces of each hand, and whole body images were acquired after 10 min and 2 hours under the same gamma camera, with the arms raised above the head. The 10-min image showed rapid movement of tracer into the left trochlear and axillary lymph nodes, with minimal tracer movement in the region of the distal right forearm. The delayed image showed diffuse soft tissue concentration of tracer only in the distal part of the right forearm, with no further ascent, indicating lymphatic obstruction [Figure 2].

Close

Figure 2 Lymphoscintigraphy at 10 minutes (a) and 2 hours; (b) with the arms raised, showing rapid movement of tracer into the left trochlear and axillary lymph nodes (arrows), and diffuse soft tissue tracer uptake in the distal part of the right forearm (arrowhead)

Export to PPT

DISCUSSION

Lymphedema is a common complication of breast cancer treatment, with a significantly higher incidence reported after axillary lymph node dissection and radiotherapy (38.3-42.4%) as compared to that by any one treatment modality alone (7.4-13.4%).[1–3] Post-mastectomy edema may be early and occur shortly after surgery, resulting from acute lymphatic overload, and decrease as compensatory pathways develop. Late lymphedema may develop months to years after surgery.[4] This condition is often progressive, attributed to lymphatic obstruction by surgical interruption or fibrosis and precipitates overload in already compromised lymphatic channels.

Extraosseous soft tissue concentration of bone imaging agents like Tc-99m MDP and Tc-99m HMDP has been reported in conditions that cause hyperemia (i.e., inflammation, neovascularity, altered sympathetic tone with resultant vasodilatation) and altered capillary permeability, resulting in increased distribution of the tracer within the soft tissues.[5–7] The exact mechanism of non-osseous accumulation of bone scanning agents is still unclear; however, it has been proposed that Tc-99m MDP accumulates in serous effusions by directly exuding from the peripheral blood vessels to the serous cavity along with the increased blood flow, the increased vascularity and vascular permeability.[89]